Nuclear receptor corepressors partner with class II histone deacetylases in a Sin3-independent repression pathway

Genes and Development

Volumn 14, Issue 1, 2000, Pages 45-54

  Huang, Eric Y ^a   Zhang, Jinsong ^a   Miska, Eric A ^b   Guenther, Matthew G ^a   Kouzarides, Tony ^b   Lazar, Mitchell A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

Chromatin; HDAC1; HDAC4; HDAC5; mSin3; N CoR; Nuclear receptors; SMRT

Indexed keywords

ADAPTOR PROTEIN; CELL NUCLEUS RECEPTOR; HISTONE DEACETYLASE; HORMONE RECEPTOR; REPRESSOR PROTEIN;

ARTICLE; CHROMATIN; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; KIDNEY CELL; MOLECULAR INTERACTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; REPRESSOR GENE; TRANSCRIPTION REGULATION;

CATALYTIC DOMAIN; CELL LINE; HISTONE DEACETYLASES; HUMANS; PRECIPITIN TESTS; PROTEIN BINDING; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRESSOR PROTEINS; SACCHAROMYCES CEREVISIAE PROTEINS; TRANSCRIPTION FACTORS;

EID: 0033957792     PISSN: 08909369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Alland, L., R. Muhle, H. Hou, J. Potes, L. Chin, N. Schreiber-Agus, and R.A. DePinho. 1997. Role for N-CoR and histone deacetylase in Sin3-mediated transcriptional repression. Nature 387:49-55.
2. Ayer, D.E., Q.A. Lawrence, and R.N. Eisenman. 1995. Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast represser Sin3. Cell 80: 767-776.
3. Blanco, J.C., S. Minucci, J. Lu, X.J. Yang, K.K. Walker, H. Chen, R.M. Evans, Y. Nakatani, and K. Ozato. 1998. The histone acetylase PCAF is a nuclear receptor coactivator. Genes & Dev. 12: 1638-1651.
4. Boyes, J., P. Byfield, Y. Nakatani, and Y. Ogryzko. 1998. Regulation of the activity of the transcription factor GATA-1 by acetylation. Nature 396: 594-598.
5. Carmen, A.A., S.E. Rundlett, and M. Grunstein. 1996. HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex. J. Biol. Chem. 271: 15837-15844.
6. Chakravarti, D., V.J. LaMorte, N.C. Nelson, T. Nakajima, I.G. Schulman, H. Juguilon, M. Montminy, and R.M. Evans. 1996. Role of CBP/p300 in nuclear receptor signaling. Nature 383: 99-103.
7. Chen, J.D. and R.M. Evans. 1995. A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377: 454-457.
8. Chen, H., R.J. Lin, W. Xie, D. Wilpitz, and R.M. Evans. 1999. Regulation of hormone-induced histone hyperacetylation and gene activation by acetylation of an acetylase. Cell 98: 675-686.
9. Fischle, W., S. Emiliani, M.J. Hendzel, T. Nagase, N. Nomura, W. Voelter, and E. Verdin. 1999. A new family of human histone deacetylases related to Saccharomyces cerevisiae HDA1p. J. Biol. Chem. 274: 11713-11720.
10. Gelmetti, V., J. Zhang, M. Fanelli, S. Minucci, P.G. Pelicci, and M.A. Lazar. 1998. Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO. Mol. Cell. Biol. 18: 7185-7191.
11. Glass, C.K., D.W. Rose, and M.G. Rosenfeld. 1997. Nuclear receptor coactivators. Curr. Opin. Cell. Biol. 9:222-232.
12. Grignani, F., S. DeMatteis, C. Nervi, L. Tomassoni, V. Gelmetti, M. Cioce, M. Fanelli, M. Ruthardt, F.F. Ferrara, I. Zamir et al. 1998. Fusion proteins of the retinoic acid receptor-α recruit histone deacetylase in promyelocytic leukaemia. Nature 391:815-818.
13. Grozinger, C.M., C.A. Hassig, and S.L. Schreiber. 1999. Three proteins define a class of human histone deacetylases related to yeast Hdalp. Proc. Natl. Acad. Sci. 96: 4868-4873.
14. Gu, W. and R.G. Roeder. 1997. Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606.
15. Hanstein, B., R. Eckner, J. DiRenzo, S. Halachmi, H. Liu, B. Searcy, R. Kurokawa, and M. Brown. 1996. P300 is a component of an estrogen receptor coactivator complex. Proc. Natl. Acad. Sci. 93: 11540-11545.
16. Hassig, C.A., T.C. Fleischer, A.N. Billin, S.L. Schreiber, and D.E. Ayer. 1997. Histone deacetylase activity is required for full transcriptional repression by mSin3A. Cell 89: 341-348.
17. Hassig, C.A., J.K. Tong, T.C. Fleischer, T. Owa, P.G. Grable, D.E. Ayer, and S.L. Schreiber. 1998. A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc. Natl. Acad. Sci. 95: 3519-3524.
18. He, L.Z., F. Guidez, C. Tribioli, D. Peruzzi, M. Ruthardt, A. Zelent, and P.P. Pandolfi. 1998. Distinct interactions of PML-RARα and PLZF-RARα with co-repressors determine differential responses to RA in APL. Nat. Genet. 18: 126-135.
19. Heinzel, T., R.M. Lavinsky, T.-M. Mullen, M. Soderstrom, C.D. Laherty, J. Torchia, W.-M. Yuang, G. Brard, S.D. Ngo, J.R. Davie et al. 1997. A complex containing N-CoR, mSin3 and histone deacetylase mediates transcriptional repression. Nature 387: 43-48.
20. Hong, S.H., G. David, C.W. Wong, A. Dejean, and M.L. Privalsky. 1997. SMRT corepressor interacts with PLZF and with the PML-retinoic acid receptor a and PLZF-RARα oncoproteins associated with acute promyelocytic leukemia. Proc. Natl. Acad. Sci. 94: 9028-9033.
21. Horlein, A.J., A.M. Naar, T. Heinzel, J. Torchia, B. Gloss, R. Kurokawa, A. Ryan, Y. Kamei, M. Soderstrom, C.K. Glass et al. 1995. Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377: 397-404.
22. Hung, H.L., J. Lau, A.Y. Kim, M.J. Weiss, and G.A. Blobel. 1999. CREB-binding protein acetylates hematopoietic transcription factor GATA-1 at functionally important sites. Mol. Cell. Biol. 19: 3496-3505.
23. Imhof, A., S.J. Yang, V.V. Ogryzko, Y. Nakatani, A.P. Wolffe, and H. Ge. 1997. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7: 689-692.
24. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S.-C. Lin, R.A. Heyman, D.W. Rose, C.K. Glass et al. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85: 403-414.
25. Korzus, E., J. Torchia, D.W. Rose, L. Xu, R. Kurokawa, E.M. McInerney, T.M. Mullen, C.K. Glass, and M.G. Rosenfeld. 1998. Transcription factor-specific requirements for coactivators and their acetyltransferase functions. Science 279: 703-707.
26. Kouzarides, T. 1999. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9: 40-48.
27. Lin, R.J., L. Nagy, S. Inoue, W. Shao, W.H. Miller, and R.M. Evans. 1998. Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature 391: 811-814.
28. Liu, L., D.M. Scolnick, R.C. Trievel, H.B. Zhang, R. Marmorstein, T.D. Halazonetis, and S.L. Berger. 1999. p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol. Cell. Biol. 19: 1202-1209.
29. Lutterbach, B., J.J. Westendorf, B. Linggi, A. Patten, M. Moniwa, J.R. Davie, K.D. Huynh, V.J. Bardwell, R.M. Lavinsky, M.G. Rosenfeld et al. 1998. ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors. Mol. Cell. Biol. 18: 7176-7184.
30. Miska, E.A., C. Karlsson, E. Langley, S.J. Nielsen, J. Pines, and T. Kouzarides. 1999. HDAC4 associates with and represses the MEF2 transcription factor. EMBO J. 18: 5099-5017.
31. Nagy, L., H.-Y. Kao, D. Chakvarkti, R.J. Lin, C.A. Hassig, D.E. Ayer, S.L. Schreiber, and R.M. Evans. 1997. Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89: 373-380.
32. Ordentlich, P., M. Downes, W. Xie, A. Genin, N.B. Spinner, and R.M. Evans. 1999. Unique forms of human and mouse nuclear receptor corepressor SMRT. Proc. Natl. Acad. Sci. 96: 2639-2644.
33. Park, E.J., D.J. Schroen, M. Yang, H. Li, L. Li, and J.D. Chen. 1999. SMRTe, a silencing mediator for retinoid and thyroid hormone receptors-extended isoform that is more related to the nuclear receptor corepressor. Proc. Natl. Acad. Sci. 96: 3519-3524.
34. Pazin, M.J. and J.T. Kadonaga. 1997. What's up and down with histone deacetylation and transcription? Cell 89: 325-328.
35. Rundlett, S.E., A.A. Carmen, R. Kobayashi, S. Bavykin, B.M. Turner, and M. Grunstein. 1996. HDA1 and RPD3 are members of distinct yeast histone deacetylase complexes that regulate silencing and transcription. Proc. Natl. Acad. Sci. 93: 14503-14508.
36. Safer, J.D., J.F. Langlois, R. Cohen, T. Monden, D. John-Hope, J. Madura, A.N. Hollenberg, and F.E. Wondisford. 1997. Isoform variable action among thyroid hormone receptor mutants provides insight into pituitary resistance to thyroid hormone. Mol. Endocrinol. 10: 16-26.
37. Seol, W., M.J. Mahon, Y.-K. Lee, and D.D. Moore. 1996. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR. Mol. Endocrinol. 10: 1646-1655.
38. Struhl, K. 1998. Histone acetylation and transcriptional regulatory mechanisms. Genes & Dev. 12: 599-606.
39. Tong, J.K., C.A. Hassig, G.R. Schnitzler, R.E. Kingston, and S.L. Schreiber. 1998. Chromatin deacetylation by an ATP-dependent nucleosome remodelling complex. Nature 395: 917-921.
40. Verdel, A. and S. Khochbin. 1999. Identification of a new family of higher eukaryotic histone deacetylases. Coordinate expression of differentiation-dependent chromatin modifiers. J. Biol. Chem. 274: 2440-2445.
41. Wade, P.A., P.L. Jones, D. Vermaak, and A.P. Wolffe. 1998. A multiple subunit Mi-2 histone deacetylase from Xenopus laevis cofractionates with an associated Snf2 superfamily ATPase. Curr. Biol. 8: 843-846.
42. Wang, J., T. Hoshino, R.L. Redner, S. Kajigaya, and J.M. Liu. 1998. ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. Proc. Natl. Acad. Sci. 95: 10860-10865.
43. Warrell, R.P., L.Z. He, E. Calleja, and P.P. Pandolfi. 1998. Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase. J. Natl. Cancer Inst. 90: 1621-1625.
44. Westin, S., R. Kurokawa, R.T. Nolte, G.B. Wisely, E.M. McInerney, D.W. Rose, M.V. Milburn, M.G. Rosenfeld, and C.K. Glass. 1998. Interactions controlling the assembly of nuclear receptor heterodimers and co-activators. Nature 395: 199-202.
45. Xu, L., R.M. Lavinsky, J.S. Dasen, S.E. Flynn, E.M. McInerney, T.M. Mullen, T. Heinzel, D. Szeto, E. Korzus, R. Durokawa et al. 1998. Signal-specific co-activator domain requirements for Pit-1 activation. Nature 395: 301-306.
46. Yoh, S.M., V.K.K. Chatterjee, and M.L. Privalsky. 1997. Thyroid hormone resistance syndrome manifests as an aberrant interaction between mutant T3 receptors and transcriptional corepressors. Mol. Endocrinol. 11: 470-480.
47. Zamir, I., H.P. Harding, G.B. Atkins, A. Horlein, C.K. Glass, M.G. Rosenfeld, and M.A. Lazar. 1996. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with different repression domains. Mol. Cell. Biol. 16: 5458-5465.
48. Zamir, I., J. Zhang, and M.A. Lazar. 1997. Stoichiometric and steric principles govering repression by nuclear hormone receptors. Genes & Dev. 11: 835-846.
49. Zhang, J., I. Zamir, and M.A. Lazar. 1997. Differential recognition of liganded and unliganded thyroid hormone receptor by retinoid X receptor regulates transcriptional repression. Mol. Cell. Biol. 17: 6887-6897.
50. Zhang, J., M.G. Guenther, R.W. Carthew, and M.A. Lazar. 1998a. Proteasomal regulation of nuclear receptor corepressor-mediated repression. Genes & Dev. 12: 1776-1880.
51. Zhang, Y., G. LeRoy, H.P. Seelig, W.S. Lane, and D. Reinberg. 1998b. The dermatomyositis-specific autoantigen Mi2 is a component of a complex containing histone deacetylase and nucelosome remodeling activities. Cell 95: 279-289.
52. Zhang, Y., Z.W. Sun, R. Iratni, B.H. Erdjument, P. Tempst, M. Hampsey, and D. Reinberg. 1998c. SAP30, a novel protein conserved between human and yeast, is a component of a histone deacetylase complex. Mol. Cell. 1: 1021-1031.
53. Zhang, Y., H.H. Ng, H. Erdjument-Bromage, P. Tempst, A. Bird, and D. Reinberg. 1999. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes & Dev. 13: 1924-1935.